Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Linezolid impurity 3 | HCID 10944967 | — |
| Edukt | 2-Oxiranepropanamide | HCID 22246713 | — |
| Edukt | 2-Propanol, 2-methyl-, lithium salt (1:1) | HCID 23664764 | — |
| Lösungsmittel | Tetrahydrofuran | HCID 8028 | — |
| Produkt | rac-Linezolid | HCID 3929 | 80% |
Reaktionsschritte
To a solution of (±)-glycidylacetamide (VIIIB, EXAMPLE 11, 0.1571 g, 1.365 mmol) in THF (1.63 ml) at −78° is added N-carbomethoxy-3-fluoro-4-morpholinylaniline (IX, PREPARATION 2, 0.4358 g, 1.71 mmol, 1.26 eq) and lithium t-butoxide (0.1267 g, 1.583 mmol, 1.16 eq). The reaction mixture is then stirred at 0 to 11° for 17.5 hrs at which point HPLC showes an 80% yield of (±)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide (retention time=0.97 min; method B; Stationary phase: 4.6×250 mm Zorbax RX C-8 column; mobile phase: 650 ml acetonitrile, 1.85 ml triethylamine, 1.30 ml acetic acid, water sufficient to make 1000 ml; flow rate: 3.0 ml/min; UV detection at 254 nm). The title compound is isolated by means known to those skilled in the art.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06362334B1 |
|---|
| Quelldatensatz | uspto-grants-2002_03 |
|---|
| ORD ID | ord-bbf218f1d6874c07b9f0b7b3b59a7e72 |
|---|
| Quellennotiz | uspto-grants-2002_03 |
|---|